Clinicopathologic characteristics and survival of patients with clinical Stage I squamous cell carcinomas of the thoracic esophagus treated with three-field lymph node dissection

Hiroyasu Igaki, Hoichi Kato, Yuji Tachimori, +4

European Journal of Cardio-Thoracic Surgery

Laparoscopic hepatectomy for hepatocellular carcinoma in cirrhotic patients

Hironori Kaneko, Masaru Tsuchiya, Yuichiro Otsuka, +4

Journal of Hepato-Biliary-Pancreatic Surgery

Surgical OncologyHepatologyGastroenterologyComplications Of CirrhosisSurgery +4

NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers

Yoko Oshima, Hideaki Shimada, Satoshi Yajima, +17

Journal of Gastroenterology

Ny-eso-1 AutoantibodyEsophagusEsophageal CancerMedicineImmunology +5

Beta-1 blocker improves survival of septic rats through preservation of gut barrier function

Katsuya Mori, Hiroshi Morisaki, Satoshi Yajima, +5

Intensive Care Medicine

InflammationSeptic RatsMedicinePhysiologyGut-organ Axis +4

Hyperfibrinogenemia is associated with inflammatory mediators and poor prognosis in patients with gastric cancer

Takashi Suzuki, Hideaki Shimada, Tatsuki Nanami, +5

Surgery Today

InflammationAutoimmune DiseaseImmunologyGastroenterologyChronic Inflammation +8

Panel of autoantibodies against multiple tumor‐associated antigens for detecting gastric cancer

Isamu Hoshino, Matsuo Nagata, Nobuhiro Takiguchi, +8

Cancer Science

Prognostic impact of CEA/CA19-9 at the time of recurrence in patients with gastric cancer

Jin Moriyama, Yoko Oshima, Tatsuki Nanami, +5

Surgery Today

Prognostic ImpactEsophageal CancerGastrointestinal OncologyMedicineGastroenterology +5

Association between venous thromboembolism and plasma levels of both soluble fibrin and plasminogen-activator inhibitor 1 in 170 patients undergoing total hip arthroplasty

Yohei Yukizawa, Yutaka Inaba, Shinichiro Watanabe, +6

Acta Orthopaedica

Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination

Hideaki Kato, Kei Miyakawa, Norihisa Ohtake, +7

Vaccine

Tumor necrosis factor-α mediates hyperglycemia-augmented gut barrier dysfunction in endotoxemia*

Satoshi Yajima, Hiroshi Morisaki, Ryohei Serita, +7

Critical Care Medicine